Benzinga | Dec 15, 2021 07:25AM EST

SVB Leerink Maintains Market Perform on Pfizer, Raises Price Target to $56

SVB Leerink analyst Geoffrey Porges maintains Pfizer (NYSE:PFE) with a Market Perform and raises the price target from $52 to $56.